---
layout: minimal-medicine
title: Rosiglitazone
---

# Rosiglitazone
### Generic Name
Rosiglitazone

### Usage
Rosiglitazone is a thiazolidinedione medication primarily used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.  It's not used for type 1 diabetes or diabetic ketoacidosis.  Importantly, it's crucial to understand that rosiglitazone's use has been significantly restricted or withdrawn in many countries due to concerns about increased cardiovascular risks, including myocardial infarction (heart attack) and stroke.  Therefore, its current availability and use may vary considerably depending on geographic location and individual physician recommendations.  This medication works by increasing the sensitivity of cells to insulin, allowing them to more effectively utilize glucose.

### Dosage
**Adult Dosage (Type 2 Diabetes Mellitus):**  The initial oral dose is typically 4 mg daily, either as a single dose or divided into two doses.  After 8-12 weeks, if blood sugar control remains inadequate (as determined by fasting plasma glucose levels), the dose may be increased to 8 mg daily. However, dose increases should be carefully monitored for adverse effects, especially fluid retention. The maximum recommended dose is 8 mg/day.  If rosiglitazone is used with other hypoglycemic agents, there's a heightened risk of hypoglycemia (low blood sugar), so the dose of the other medication may need adjustment.

**Pediatric Dosage:** The safety and efficacy of rosiglitazone in children have not been established.  It should not be used in children.

**Dosage Adjustments:** No specific dosage adjustments are generally recommended for renal impairment. However, individuals with hepatic (liver) impairment require cautious use; the medication should not be started if active liver disease or elevated liver enzymes are present.  Clearance is significantly reduced in those with liver problems.

### Side Effects
**Common Side Effects:**

* Increased HDL cholesterol, LDL cholesterol, and total cholesterol levels
* Weight gain
* Headache
* Edema (swelling)

**Less Common but Serious Side Effects:**

* Hypertension (high blood pressure)
* Congestive heart failure
* Ischemic heart disease (reduced blood flow to the heart)
* Hypoglycemia (low blood sugar)
* Diarrhea
* Anemia
* Bone fractures (particularly in women)
* Arthralgia (joint pain)
* Back pain
* Liver damage (hepatitis, jaundice)
* Macular edema (swelling of the macula in the eye)
* Myocardial infarction (heart attack)
* Allergic reactions (anaphylaxis, angioedema, rash, etc.)

**Note:**  This is not an exhaustive list. If any adverse effects occur, it is crucial to consult a healthcare professional immediately.


### How it Works
Rosiglitazone belongs to a class of drugs called thiazolidinediones. It works by activating peroxisome proliferator-activated receptor-gamma (PPAR-γ), a type of nuclear receptor found in fat cells, muscle cells, and the liver.  Activating PPAR-γ improves insulin sensitivity, meaning cells can better utilize glucose from the bloodstream, thereby lowering blood sugar levels.  Crucially, it primarily works by improving cellular responsiveness to insulin, rather than directly stimulating the pancreas to produce more insulin.  However, increased fluid retention (edema) can occur as a side effect due to PPAR-γ’s influence on sodium reabsorption in the kidneys.


### Precautions
**Contraindications:** Rosiglitazone is contraindicated in patients with hypersensitivity to the drug or its components, and in those with NYHA Class III or IV heart failure (severe heart failure).

**Warnings:** Rosiglitazone carries a significant risk of congestive heart failure and increased cardiovascular events. Patients should be carefully monitored for signs of heart failure (weight gain, shortness of breath, edema).  It increases the risk of fluid retention, bone fractures (particularly in women), and liver problems.  Use caution in patients with pre-existing edema, anemia, or elevated liver enzymes. The concurrent use of other hypoglycemic medications may increase the risk of hypoglycemia. Rosiglitazone use is not recommended in pregnant or breastfeeding women due to potential risks to the fetus or infant.

**Drug Interactions:** Inhibitors of CYP2C8 (e.g., gemfibrozil) can increase rosiglitazone levels, while inducers (e.g., rifampin) can decrease them.  This may necessitate adjustments in diabetes treatment depending on clinical response.


### FAQs
* **Q: Can I take rosiglitazone with or without food?** A: Rosiglitazone may be taken with or without food.

* **Q: How should I store rosiglitazone?** A: Store rosiglitazone as directed on the product label, typically at room temperature away from moisture and light.

* **Q: What should I do if I miss a dose?** A: Take the missed dose as soon as you remember, unless it is almost time for your next dose.  Do not double the dose.

* **Q: Is rosiglitazone safe for everyone?** A: No, rosiglitazone is not safe for everyone.  It carries significant cardiovascular risks and should only be used under strict medical supervision. Individuals with liver or heart problems should use it with extreme caution or avoid it altogether.

* **Q: Can I stop taking rosiglitazone suddenly?** A: It's best not to stop taking rosiglitazone suddenly;  consult your doctor for guidance on gradually discontinuing the medication.

* **Q: What should I do if I experience side effects?** A: Contact your healthcare provider immediately if you experience any adverse effects, particularly those mentioned earlier in the side effects section.


**Disclaimer:**  This information is intended for general knowledge and does not constitute medical advice.  Always consult a healthcare professional for diagnosis and treatment of medical conditions, and before making any decisions related to your health or medication.  The availability and use of rosiglitazone may be restricted in certain regions.  This information should not be considered a substitute for professional medical advice.
